324.79
price down icon1.22%   -4.02
after-market 시간 외 거래: 324.79
loading
전일 마감가:
$328.81
열려 있는:
$329
하루 거래량:
1.03M
Relative Volume:
1.12
시가총액:
$42.35B
수익:
$2.35B
순이익/손실:
$-269.70M
주가수익비율:
-155.40
EPS:
-2.09
순현금흐름:
$-75.39M
1주 성능:
+1.33%
1개월 성능:
+0.61%
6개월 성능:
+16.33%
1년 성능:
+38.30%
1일 변동 폭
Value
$324.78
$331.43
1주일 범위
Value
$320.18
$332.19
52주 변동 폭
Value
$205.87
$333.70

Alnylam Pharmaceuticals Inc Stock (ALNY) Company Profile

Name
명칭
Alnylam Pharmaceuticals Inc
Name
전화
(617) 551-8200
Name
주소
675 WEST KENDALL STREET, CAMBRIDGE, MA
Name
직원
2,230
Name
트위터
@alnylam
Name
다음 수익 날짜
2024-10-31
Name
최신 SEC 제출 서류
Name
ALNY's Discussions on Twitter

ALNY을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
324.79 42.87B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
460.83 120.60B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.63 60.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ARGX
Argen X Se Adr
595.19 36.23B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.51 31.54B 3.81B -644.79M -669.77M -6.24

Alnylam Pharmaceuticals Inc Stock (ALNY) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-07-21 개시 Truist Buy
2025-03-31 개시 Redburn Atlantic Buy
2025-03-24 업그레이드 JP Morgan Neutral → Overweight
2024-11-12 다운그레이드 Wolfe Research Peer Perform → Underperform
2024-10-16 개시 Scotiabank Sector Outperform
2024-08-16 업그레이드 Goldman Neutral → Buy
2024-02-16 다운그레이드 Goldman Buy → Neutral
2024-02-15 개시 Wolfe Research Peer Perform
2023-12-08 개시 Wells Fargo Equal Weight
2023-10-11 다운그레이드 Oppenheimer Outperform → Perform
2023-09-29 개시 Raymond James Outperform
2023-05-05 업그레이드 BMO Capital Markets Market Perform → Outperform
2023-04-26 개시 SMBC Nikko Neutral
2023-03-21 개시 Bernstein Outperform
2023-01-18 개시 Canaccord Genuity Buy
2022-09-09 재개 Morgan Stanley Equal-Weight
2022-07-13 개시 Cantor Fitzgerald Neutral
2022-06-27 다운그레이드 Guggenheim Buy → Neutral
2022-06-07 개시 William Blair Outperform
2022-04-25 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2022-03-01 개시 Citigroup Buy
2022-02-03 업그레이드 Guggenheim Neutral → Buy
2022-01-03 업그레이드 Piper Sandler Neutral → Overweight
2021-11-22 업그레이드 Goldman Neutral → Buy
2021-11-22 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2021-11-01 업그레이드 Oppenheimer Perform → Outperform
2021-10-04 업그레이드 UBS Neutral → Buy
2021-08-04 다운그레이드 Piper Sandler Overweight → Neutral
2021-02-22 다운그레이드 Guggenheim Buy → Neutral
2021-02-12 다운그레이드 Citigroup Buy → Neutral
2021-02-12 재확인 H.C. Wainwright Buy
2021-01-25 다운그레이드 BMO Capital Markets Outperform → Market Perform
2020-09-30 재개 Berenberg Hold
2020-09-08 개시 Citigroup Buy
2020-08-11 다운그레이드 Oppenheimer Outperform → Perform
2020-05-13 개시 RBC Capital Mkts Sector Perform
2020-05-07 다운그레이드 JP Morgan Overweight → Neutral
2020-04-24 재개 Evercore ISI Outperform
2020-03-19 개시 Berenberg Buy
2019-12-19 재확인 Chardan Capital Markets Buy
2019-11-20 개시 Oppenheimer Outperform
2019-11-13 개시 BofA/Merrill Buy
2019-05-23 재개 Goldman Neutral
2019-04-12 개시 Evercore ISI Outperform
2019-03-06 업그레이드 Evercore ISI In-line → Outperform
2019-03-05 업그레이드 Morgan Stanley Equal-Weight → Overweight
2019-01-23 개시 UBS Neutral
2018-10-01 개시 Cantor Fitzgerald Overweight
2018-08-13 재확인 Stifel Buy
2018-08-07 업그레이드 Stifel Hold → Buy
2018-05-04 재확인 Stifel Hold
2018-03-28 개시 Evercore ISI In-line
모두보기

Alnylam Pharmaceuticals Inc 주식(ALNY)의 최신 뉴스

pulisher
Jul 28, 2025

What are Alnylam Pharmaceuticals Inc. company’s key revenue driversStay informed with daily expert analysis - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What makes Alnylam Pharmaceuticals Inc. stock price move sharplyMaximize gains with proven stock analysis - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

How does Alnylam Pharmaceuticals Inc. compare to its industry peersDiscover undervalued stocks before they soar - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are analysts’ price targets for Alnylam Pharmaceuticals Inc. in the next 12 monthsUncover the best stocks for explosive growth - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Why Alnylam Pharmaceuticals Inc. stock attracts strong analyst attentionFree Join Group - metal.it

Jul 27, 2025
pulisher
Jul 27, 2025

What are the latest earnings results for Alnylam Pharmaceuticals Inc.Overwhelming financial success - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How does Alnylam Pharmaceuticals Inc. generate profit in a changing economyInvest smarter with data-backed trading alerts - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

When is Alnylam Pharmaceuticals Inc. stock expected to show significant growthInvest in stocks with strong fundamentals - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 25, 2025

Alnylam Pharmaceuticals, Inc. (ALNY) Gets EU Nod for AMVUTTRA - Yahoo Finance

Jul 25, 2025
pulisher
Jul 25, 2025

Alnylam, Halozyme among latest firms to win EU backing for drugs - MSN

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Alnylam Pharmaceuticals Inc. stock priceDynamic investment growth - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Alnylam Pharmaceuticals Inc. stockSuperior profit margins - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release - Yahoo Finance

Jul 24, 2025
pulisher
Jul 23, 2025

Here's How Much $100 Invested In Alnylam Pharmaceuticals 15 Years Ago Would Be Worth Today - Benzinga

Jul 23, 2025
pulisher
Jul 23, 2025

Huntington's Disease Clinical, Companies, Therapeutic - openPR.com

Jul 23, 2025
pulisher
Jul 22, 2025

Alnylam Pharmaceuticals Inc. Stock Analysis and ForecastPowerful profit generation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Alnylam Pharmaceuticals Surges to Top 277 Most Actively Traded Stocks with $412 Million in Trading Volume Following FDA Approval of Patisiran - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

Is Alnylam Pharmaceuticals Inc. a good long term investmentHigh-profit capital plays - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Market Sentiment Around Loss-Making Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) - 富途牛牛

Jul 22, 2025
pulisher
Jul 22, 2025

Alnylam (ALNY) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance

Jul 22, 2025
pulisher
Jul 21, 2025

10 Most Undervalued Healthcare Stocks to Buy According to Analysts - Insider Monkey

Jul 21, 2025
pulisher
Jul 21, 2025

Lexicography: Clear And Unequivocal - The National Law Review

Jul 21, 2025
pulisher
Jul 21, 2025

Lobbying Update: $390,000 of ALNYLAM PHARMACEUTICALS INC. lobbying was just disclosed - Quiver Quantitative

Jul 21, 2025
pulisher
Jul 21, 2025

Truist Securities initiates Alnylam Pharmaceuticals stock with Buy rating By Investing.com - Investing.com Canada

Jul 21, 2025
pulisher
Jul 21, 2025

This Target Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday - Benzinga

Jul 21, 2025
pulisher
Jul 21, 2025

This Alnylam Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Jul 21, 2025
pulisher
Jul 19, 2025

Alnylam’s ELEVATE Study: A Closer Look at AHP Treatment and Market Impact - The Globe and Mail

Jul 19, 2025
pulisher
Jul 18, 2025

Alnylam Pharmaceuticals’ Phase 2 Trial: A Potential Breakthrough in Cerebral Amyloid Angiopathy Treatment - TipRanks

Jul 18, 2025
pulisher
Jul 18, 2025

Alnylam’s ALN-4324: A Promising Step in Obesity Treatment - TipRanks

Jul 18, 2025

Alnylam Pharmaceuticals Inc (ALNY) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$595.19
price up icon 0.54%
biotechnology ONC
$294.51
price up icon 1.04%
$112.79
price down icon 2.19%
$558.63
price down icon 0.79%
$27.45
price down icon 4.26%
자본화:     |  볼륨(24시간):